1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurologic Disorders Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Central Nervous System (CNS)
1.2.3 Peripheral Nervous System (PNS)
1.3 Market by Application
1.3.1 Global Neurologic Disorders Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Paralysis
1.3.3 Muscle Weakness
1.3.4 Poor Coordination
1.3.5 Loss of Sensation
1.3.6 Seizures
1.3.7 Confusion
1.3.8 Pain and Altered Levels of Consciousness
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Neurologic Disorders Therapeutics Market Perspective (2017-2028)
2.2 Neurologic Disorders Therapeutics Growth Trends by Region
2.2.1 Neurologic Disorders Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Neurologic Disorders Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Neurologic Disorders Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Neurologic Disorders Therapeutics Market Dynamics
2.3.1 Neurologic Disorders Therapeutics Industry Trends
2.3.2 Neurologic Disorders Therapeutics Market Drivers
2.3.3 Neurologic Disorders Therapeutics Market Challenges
2.3.4 Neurologic Disorders Therapeutics Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Neurologic Disorders Therapeutics Players by Revenue
3.1.1 Global Top Neurologic Disorders Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Neurologic Disorders Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Neurologic Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurologic Disorders Therapeutics Revenue
3.4 Global Neurologic Disorders Therapeutics Market Concentration Ratio
3.4.1 Global Neurologic Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurologic Disorders Therapeutics Revenue in 2021
3.5 Neurologic Disorders Therapeutics Key Players Head office and Area Served
3.6 Key Players Neurologic Disorders Therapeutics Product Solution and Service
3.7 Date of Enter into Neurologic Disorders Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Neurologic Disorders Therapeutics Breakdown Data by Type
4.1 Global Neurologic Disorders Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Neurologic Disorders Therapeutics Forecasted Market Size by Type (2023-2028) 5 Neurologic Disorders Therapeutics Breakdown Data by Application
5.1 Global Neurologic Disorders Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Neurologic Disorders Therapeutics Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Neurologic Disorders Therapeutics Market Size (2017-2028)
6.2 North America Neurologic Disorders Therapeutics Market Size by Type
6.2.1 North America Neurologic Disorders Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Neurologic Disorders Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Neurologic Disorders Therapeutics Market Share by Type (2017-2028)
6.3 North America Neurologic Disorders Therapeutics Market Size by Application
6.3.1 North America Neurologic Disorders Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Neurologic Disorders Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Neurologic Disorders Therapeutics Market Share by Application (2017-2028)
6.4 North America Neurologic Disorders Therapeutics Market Size by Country
6.4.1 North America Neurologic Disorders Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Neurologic Disorders Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Neurologic Disorders Therapeutics Market Size (2017-2028)
7.2 Europe Neurologic Disorders Therapeutics Market Size by Type
7.2.1 Europe Neurologic Disorders Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Neurologic Disorders Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Neurologic Disorders Therapeutics Market Share by Type (2017-2028)
7.3 Europe Neurologic Disorders Therapeutics Market Size by Application
7.3.1 Europe Neurologic Disorders Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Neurologic Disorders Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Neurologic Disorders Therapeutics Market Share by Application (2017-2028)
7.4 Europe Neurologic Disorders Therapeutics Market Size by Country
7.4.1 Europe Neurologic Disorders Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Neurologic Disorders Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Neurologic Disorders Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Type
8.2.1 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Neurologic Disorders Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Application
8.3.1 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Neurologic Disorders Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Region
8.4.1 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Neurologic Disorders Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Neurologic Disorders Therapeutics Market Size (2017-2028)
9.2 Latin America Neurologic Disorders Therapeutics Market Size by Type
9.2.1 Latin America Neurologic Disorders Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Neurologic Disorders Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Neurologic Disorders Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Neurologic Disorders Therapeutics Market Size by Application
9.3.1 Latin America Neurologic Disorders Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Neurologic Disorders Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Neurologic Disorders Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Neurologic Disorders Therapeutics Market Size by Country
9.4.1 Latin America Neurologic Disorders Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Neurologic Disorders Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Neurologic Disorders Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type
10.2.1 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Neurologic Disorders Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application
10.3.1 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Neurologic Disorders Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Country
10.4.1 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Neurologic Disorders Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 Biogen Inc.
11.1.1 Biogen Inc. Company Details
11.1.2 Biogen Inc. Business Overview
11.1.3 Biogen Inc. Neurologic Disorders Therapeutics Introduction
11.1.4 Biogen Inc. Revenue in Neurologic Disorders Therapeutics Business (2017-2022)
11.1.5 Biogen Inc. Recent Developments
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 F. Hoffmann-La Roche Ltd. Company Details
11.2.2 F. Hoffmann-La Roche Ltd. Business Overview
11.2.3 F. Hoffmann-La Roche Ltd. Neurologic Disorders Therapeutics Introduction
11.2.4 F. Hoffmann-La Roche Ltd. Revenue in Neurologic Disorders Therapeutics Business (2017-2022)
11.2.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.3 Johnson & Johnson Services Inc.
11.3.1 Johnson & Johnson Services Inc. Company Details
11.3.2 Johnson & Johnson Services Inc. Business Overview
11.3.3 Johnson & Johnson Services Inc. Neurologic Disorders Therapeutics Introduction
11.3.4 Johnson & Johnson Services Inc. Revenue in Neurologic Disorders Therapeutics Business (2017-2022)
11.3.5 Johnson & Johnson Services Inc. Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Neurologic Disorders Therapeutics Introduction
11.4.4 Novartis AG Revenue in Neurologic Disorders Therapeutics Business (2017-2022)
11.4.5 Novartis AG Recent Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Company Details
11.5.2 Pfizer Inc. Business Overview
11.5.3 Pfizer Inc. Neurologic Disorders Therapeutics Introduction
11.5.4 Pfizer Inc. Revenue in Neurologic Disorders Therapeutics Business (2017-2022)
11.5.5 Pfizer Inc. Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
